Clinical Trial Update: Combination Study of SV-BR-1-GM With Retifanlimab [Phase 1, Phase 2]

View source ↗

Summary

BriaCell Therapeutics Corporation completed a Phase 1/2 trial evaluating the combination of SV-BR-1-GM with retifanlimab in breast cancer, including metastatic …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Retifanlimab (retifanlimab)
• SV-BR-1-GM

Snippet

Sponsor: BriaCell Therapeutics Corporation | Conditions: Breast Cancer, Breast Neoplasm | Phase 1, Phase 2 | Status: COMPLETED